Marker Therapeutics Inc MRKR Q1 2026 Earnings EPS Beat Expectations Amid Development Stage Operations LUMN Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Restructuring Challenges Persist PBHC Q4 2025 Earnings Negative EPS of 111 Amidst a Challenging Quarter US Bancorp Q1 2026 Earnings EPS Beats Estimates Amid Stable Operations JRSH Q1 2026 Earnings Stunning EPS Beat Highlights Operational Efficiency Amid Challenging Environment MGP Ingredients MGPI Q1 2026 Earnings Earnings Surge Past Estimates Yet Stock Edges Lower Plexus Corp Q1 2026 Earnings EPS Beats Estimates by 678 Revenue Data Withheld Grupo Aeroportuario del Sureste SA de CV ASR Q1 2026 Earnings EPS Miss Weighs on Shares Despite Steady Traffic Trends Addex Therapeutics Q1 2024 Earnings PreRevenue Biotech Advances Pipeline Amid Narrowing Losses OPRA Q1 2026 Earnings EPS Tops Estimates as Opera Delivers Modest Beat American Healthcare REIT Inc AHR Q1 2026 Earnings Positive EPS Surprise Amid Revenue Ambiguity Cerus Corporation Q1 2026 Earnings Narrowing Loss Beats Estimates Amid Operational Progress